Rapamycin joins the aging fray

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 6, 2010, Pages 577-579

  Sierra, Felipe ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; SIGNAL PEPTIDE;

AGING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LONGEVITY; NOTE; PHYSIOLOGY;

AGING; ANIMALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LONGEVITY; PROTEIN-SERINE-THREONINE KINASES; SIROLIMUS;

EID: 77952977261     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq049     Document Type: Review

References (9)

1. Sharp Z, Strong R. The role of mTOR signaling in controlling mammalian lifespan: what a fungicide teaches us about longevity. J Gerontol A Biol Sci Med Sci. 2010;65(6):580-589.
2. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392- 395.
3. Nadon NL, Strong R, Miller RA, et al. design of aging intervention studies: the niA interventions testing program. Age. 2008;30(4):187-199.
4. Strong R, Miller RA, Astle CM, et al. nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7(5):641-650.
5. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
6. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8(2):157-168.
7. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mTOR, Ab and tau: effects on cognitive impairments. J Biol Chem. 2010;284(40):27416-27424.
8. Spilman P, Podlutskaya N, Hart MJ, et al. inhibition of mTOR by rapamycin abolishes cognitive defcits and reduces amyloid-b levels in a mouse model of Alzheimer's disease. PLoS One. 2010; 5(4):e9979.
9. Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, greene LA. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci. 2010;30(3): 1166-1175.